HIV prevention drug could reduce cases globally but USAID cuts prevent access, say experts

Published July 31, 2026 · Category: News

Overview

Injectable PrEP drug holds promise but investment in HIV prevention has declined dramatically worldwide

• Sign up for the Breaking News US newsletter email

New innovations in HIV prevention could dramatically reduce the number of new HIV cases around the globe, but US foreign aid cuts will mean that those that most need the new medication will be unable to access it, according to experts at the Aids 2026 Conference in Rio de Janeiro, Brazil.

Details

One year ago, the World Health Organization recommended that governments around the world prioritize expanded access to lenacapavir, an injectable version of the HIV prevention medication PrEP that requires only two injections annually. PrEP, which also comes in the form of daily oral medications and bimonthly injections, is 99% effective in preventing sexually transmitted HIV for people who take it consistently.

Source

Originally published at www.theguardian.com.

Related Articles

• Sam Fender and Olivia Dean’s Rein Me In breaks 73-year record to become longest-running UK No 1 single
• How Sam Fender and Olivia Dean's Rein Me In broke the UK's singles chart record
• DR Congo Ebola epidemic becomes world’s second largest outbreak